The Multiple Myeloma Treatment Paradigm
Jointly provided by
Impact Education, LLC    
This activity is supported by an independent educational grant from Celgene Corporation.

You Are Invited to a LIVE CME/CPE/CNE Webcast:
The Multiple Myeloma Treatment Paradigm: Addressing an Evolving and Multifaceted Process Live Webcast

Live Webcast Dates

Tuesday October 16, 2018 12:30 PM - 2:00 PM ET
Wednesday October 31, 2018 12:30 PM - 2:00 PM ET
Tuesday November 13, 2018 1:00 PM - 2:30 PM ET

Click here to download the slides from this webcast series.

  • Recent clinical data on new and emerging multiple myeloma (MM) therapies
  • Health coaching strategies to increase patient engagement
  • Care pathways initiatives as a means of reducing treatment variability and improving clinical and economic outcomes
Vanita Pindolia, PharmD, BCPS, MBA
Vice President, Ambulatory Clinical Pharmacy Programs_PCM
Henry Ford Health System/Health
Alliance Plan of Michigan
David Vesole, MD, PhD
Co-Director, Myeloma Division and
Director, Myeloma Research, John Theurer Cancer Center, Hackensack University Medical Center
Director of the Myeloma Program
MedStar Georgetown University Hospital
Professor of Medicine, Georgetown University
Edmund Pezalla, MD, MPH
Enlightenment Bioconsult, LLC
  • Managed care pharmacy directors, clinical pharmacists, quality directors, medical directors
  • Pharmacy directors, specialty pharmacists, quality directors, registered nurses, care managers, and other managed care and payer organization professionals

The management of multiple myeloma (MM) is a priority area for MCOs in order to optimize clinically- and economically-appropriate care for their members. As novel agents become available, treatment decision making is becoming more complex and MCOs and other payer organizations need to appropriately and effectively design benefits that optimize both cost-efficiency and patient outcomes. Guidance is needed for the target audience to implement current guidelines, utilize clinical pathways, design appropriate medical and pharmacy benefits, and implement effective specialty pharmacy management services.

This interactive program is designed to engage the faculty and audience to develop solutions for managed care professionals to implement within their own setting to improve outcomes for patients with MM. Multidisciplinary faculty will be utilized featuring a managed care medical director, a pharmacy director, and a hematology/oncology expert.


After completing the activity, participants should be better able to:
  • Evaluate recent clinical data on new and emerging MM therapies
  • Align managed care MM treatment algorithms with recent clinical trial data
  • Employ health coaching strategies to increase patient engagement in their care and enhance outcomes
  • Demonstrate the value of care pathways initiatives as a means of reducing treatment variability and improving clinical and economic outcomes in the management of MM
Introduction and Overview
Vanita Pindolia, PharmD, BCPS, MBA
Treatment Sequences and Combinations in Multiple Myeloma Management
David Vesole, MD, PhD
Can Care Pathways Reduce Treatment Variability and Improve Outcomes?
Edmund Pezalla, MD, MPH
Managed Care and Specialty Pharmacy Management Approaches to Enhance Quality of Cost of Care
Vanita Pindolia, PharmD, BCPS, MBA
Audience Question and Answer Session

Key Takeaways and Closing Comments
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Impact Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number - JA4008162-9999-18-262-L01-P
Type of Activity: Application

For Pharmacists: Pharmacists have up to 30 days to complete the evaluation and claim credit for participation so that information can be submitted to the CPE Monitor as required. After receipt of a completed activity evaluation form, you will be provided with instructions to have your credit immediately uploaded to the CPE Monitor.

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours.

Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education (IPCE) credit for learning and change.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Hardware/Software Requirements
Compatible with Internet Explorer 6 and up, Mozilla Firefox 3 and up, Safari 4.0, and Google Chrome 10 and up.

Fee Information
There is no fee for this educational activity.

Policy on Privacy and Confidentiality
Please see final activity for the policy on privacy and confidentiality that relates to this internet activity.

If you have any questions, please call (215) 619-8812 or email